ChemInform Abstract: POTENTIAL BROAD SPECTRUM ANTHELMINTICS. PART 4: DESIGN, SYNTHESIS AND SPECTRAL STUDY OF IMIDAZO(2,1-B)-1,3,4-THIADIAZOLE DERIVATIVES

1979 ◽  
Vol 10 (28) ◽  
Author(s):  
M. A. ELDAWY ◽  
S. A. SHAMS EL-DINE ◽  
K. M. EL-BREMBALY
2001 ◽  
Vol 44 (26) ◽  
pp. 4563-4576 ◽  
Author(s):  
W. G. Rajeswaran ◽  
Yang Cao ◽  
Xi-Ping Huang ◽  
Mary Elizabeth Wroblewski ◽  
Tracy Colclough ◽  
...  

2020 ◽  
Vol 11 (12) ◽  
pp. 1379-1385
Author(s):  
R. Kirk ◽  
A. Ratcliffe ◽  
G. Noonan ◽  
M. Uosis-Martin ◽  
D. Lyth ◽  
...  

We disclose the discovery of REDX07965, a novel tricyclic topoisomerase inhibitor (NTTI) which has broad spectrum activity, favourable in vitro pharmacokinetic properties and selectivity versus human topoisomerase II.


2016 ◽  
Vol 71 (3) ◽  
pp. 205-210 ◽  
Author(s):  
Ali Almasirad ◽  
Loghman Firoozpour ◽  
Maliheh Nejati ◽  
Najmeh Edraki ◽  
Omidreza Firuzi ◽  
...  

AbstractA series of novel 1,3,4-thiadiazole derivatives bearing an amide moiety were designed, synthesized, and evaluated for their in vitro antitumor activities against HL-60, SKOV-3 and MOLT-4 human tumor cell lines by MTT assay. Ethyl 2-((5-(4-methoxybenzamido)-1,3,4-thiadiazol-2-yl)thio)acetate (5f) showed the best inhibitory effect against SKOV-3 cells, with an IC50 value of 19.5 μm. In addition, the acridine orange/ethidium bromide staining assay in SKOV-3 cells suggested that the cytotoxic activity of 5f occurs via apoptosis.


Sign in / Sign up

Export Citation Format

Share Document